Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (291-300 of 621) with videos related to

Pageof 63
Sort By:
Arthritis and Rheumatism|March 2, 2011
Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosisJérôme Avouac, Barbara G Fürnrohr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosisChristian Beyer, Nicole Reich, Sonia C Schindler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosisJérôme Avouac, Katrin Palumbo-Zerr, Nadira Ruzehaji, et al.
Orphanet Journal of Rare Diseases|August 10, 2021
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, et al.
Cell Reports|July 2, 2020
The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg DevelopmentFlorian Renoux, Mara Stellato, Claudia Haftmann, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
CD90-positive stromal cells associate with inflammatory and fibrotic changes in modic changesStefan Dudli, Agnieszka Karol, Luca Giudici, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
The Journal of Rheumatology|February 1, 2024
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed TomographyCosimo Bruni, Lorenzo Tofani, Alexandru Garaiman, et al.
Arthritis and Rheumatism|March 5, 2010
MicroRNA-29, a key regulator of collagen expression in systemic sclerosisBritta Maurer, Joanna Stanczyk, Astrid Jüngel, et al.
Pageof 63

Showing results (291-300 of 621) with videos related to

Sort By:
Pageof 63
Arthritis and Rheumatism|March 2, 2011
Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosisJérôme Avouac, Barbara G Fürnrohr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosisChristian Beyer, Nicole Reich, Sonia C Schindler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosisJérôme Avouac, Katrin Palumbo-Zerr, Nadira Ruzehaji, et al.
Orphanet Journal of Rare Diseases|August 10, 2021
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, et al.
Cell Reports|July 2, 2020
The AP1 Transcription Factor Fosl2 Promotes Systemic Autoimmunity and Inflammation by Repressing Treg DevelopmentFlorian Renoux, Mara Stellato, Claudia Haftmann, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
CD90-positive stromal cells associate with inflammatory and fibrotic changes in modic changesStefan Dudli, Agnieszka Karol, Luca Giudici, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
The Journal of Rheumatology|February 1, 2024
Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed TomographyCosimo Bruni, Lorenzo Tofani, Alexandru Garaiman, et al.
Arthritis and Rheumatism|March 5, 2010
MicroRNA-29, a key regulator of collagen expression in systemic sclerosisBritta Maurer, Joanna Stanczyk, Astrid Jüngel, et al.
Pageof 63